← Back to Clinical Trials
Recruiting NCT07278414

NCT07278414 Assessing and Addressing Health-Related Social Needs Among Families of Children With Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07278414
Status Recruiting
Phase
Sponsor Wake Forest University Health Sciences
Condition Childhood Cancers
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2026-01-07
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Community Enhancing Resources for Childhood cAncer support (CERCA)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2026-01-07 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to design Community Enhancing Resources for Childhood cAncer support (CERCA) and refine intervention procedures to target Health-related Social Needs (HRSN) in families of children with cancer. CERCA will leverage existing community resources and create partnerships that will lead to sustainable outcomes. The hypothesis is that through context-driven co-design and community-engaged research methods, the study team will develop an acceptable intervention to target unmet HRSN in families of children with cancer.

Eligibility Criteria

Inclusion Criteria: Caregivers of Children with Cancer * A caregiver of a child (\<18 years old) actively receiving treatment or recently completed treatment (within the past 1 year prior to enrollment) for any type of cancer. A caregiver is defined as any individual involved in bringing the child to the clinic or providing care at home, the hospital, or other healthcare setting (e.g., parents, guardians, siblings, etc.). * Ability to understand IRB-approved information sheet and willingness to provide consent. * Age ≥ 18 years at the time of consent. * Ability to understand the English and/or Spanish language. Community-based Organizations * Representative of community-based organizations that provide resources for families of children with cancer * Ability to understand IRB-approved information sheet and willingness to provide consent. * Age ≥ 18 years at the time of consent. * Ability to understand English and/or Spanish language. Healthcare Professionals * Physicians, advanced practice practitioners, nurses, clinical social workers, medical assistants, clinic patient service representatives, and cancer center administrators at AHWFBC. * Ability to understand IRB-approved information sheet and willingness to provide consent. * Age ≥ 18 years at the time of consent. * Ability to understand English and/or Spanish language. Exclusion Criteria: * There are no specific exclusion criteria.

Contact & Investigator

Central Contact

Katherine Brinkley

✉ katherine.brinkley@advocatehealth.org

📞 336-702-4483

Principal Investigator

Joanna M Robles, MD

PRINCIPAL INVESTIGATOR

Wake Forest University Health Sciences

Frequently Asked Questions

Who can join the NCT07278414 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Childhood Cancers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07278414 currently recruiting?

Yes, NCT07278414 is actively recruiting participants. Contact the research team at katherine.brinkley@advocatehealth.org for enrollment information.

Where is the NCT07278414 trial being conducted?

This trial is being conducted at Winston-Salem, United States.

Who is sponsoring the NCT07278414 clinical trial?

NCT07278414 is sponsored by Wake Forest University Health Sciences. The principal investigator is Joanna M Robles, MD at Wake Forest University Health Sciences. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology